Novartis (NYSE: NVS) is a major Swiss drug company with a market capitalization of over $300 billion. Its focus areas are extensive, spanning oncology, immunology, neuroscience, respiratory care, and cardiovascular, renal, and metabolic diseases. With a strong operating history and a diversified business,
The pharmaceutical giant could be an attractive stock for more conservative investors. Let’s dive in and take a closer look to see why.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »
Novartis is one of the world’s largest healthcare companies. That alone doesn’t make it worth buying, but it speaks to the scale of the business and its historical success. A company doesn’t achieve this level of scale and industry dominance by accident. Management…



